# LadRx Corp

LadRx Corp is a company headquartered in Los Angeles, CA, United States.

## Company overview

- **Legal name:** LadRx Corp
- **Former names in filing history:** CYTRX CORP (1995-11-07 to 2022-09-23)
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Los Angeles, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000799698

## About

LadRx Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000799698, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2025-03-28, it reported net income of USD -1,589,685; total assets of USD 839,512 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Net income:** -$1.6M (USD -1,589,685)
- **Total assets:** $839,512 (USD 839,512)
- **Cash and equivalents:** $759,742 (USD 759,742)
- **Operating cash flow:** -$1.3M (USD -1,310,333)

### FY2023 (period ended 2023-12-31)

- **Net income:** $400,443 (USD 400,443)
- **Total assets:** $2.3M (USD 2,307,882)
- **Cash and equivalents:** $2.1M (USD 2,070,075)
- **Operating cash flow:** $1.0M (USD 1,013,892)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2022 (period ended 2022-12-31)

- **Net income:** -$4.2M (USD -4,200,573)
- **Total assets:** $2.2M (USD 2,246,772)
- **Cash and equivalents:** $1.4M (USD 1,374,992)
- **Operating cash flow:** -$4.8M (USD -4,832,464)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$13.2M (USD -13,176,663)
- **Total assets:** $8.7M (USD 8,726,777)
- **Cash and equivalents:** $6.8M (USD 6,769,603)
- **Operating cash flow:** -$12.3M (USD -12,308,890)

## Recent SEC filings

- Form 8-K — filed 2025-07-31 — period 2025-06-11 — 8-K
- Form 8-K — filed 2025-06-27 — period 2025-06-11 — 8-K
- Form 10-Q — filed 2025-05-14 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-04-16 — period 2025-04-14
- Form 10-K — filed 2025-03-28 — period 2024-12-31
- Form 10-Q — filed 2024-11-14 — period 2024-09-30
- Form 8-K — filed 2024-10-09 — period 2024-10-04
- Form DEF 14A — filed 2024-08-20 — period 2024-08-20
- Form 10-Q — filed 2024-08-14 — period 2024-06-30
- Form 8-K — filed 2024-06-06 — period 2024-06-03
- Form 10-Q — filed 2024-05-15 — period 2024-03-31
- Form 10-K — filed 2024-03-27 — period 2023-12-31

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/ladrx-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology